News
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
Most U.S. adults find the information to be at least somewhat reliable, new research shows. But experts say there is ...
Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated podcasts could serve as a cost-effective, scalable way for healthcare ...
Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.
Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...
If agentic AI is to be successful, companies will have to figure out how to protect data. With that in mind, several big tech players now offer their own flavor of confidential computing.
At least 15,000 healthcare professionals across Vietnam will benefit from the “AI Opportunity for Healthcare Professionals” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results